{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:07:46Z","timestamp":1788995266795,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejps.2026.107637","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:07:18Z","timestamp":1786774038000},"page":"107637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential myocardial responses to indobufen and aspirin across clinical and experimental models of myocardial infarction"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-8915","authenticated-orcid":false,"given":"Bryan Richard","family":"Sasmita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-8452","authenticated-orcid":false,"given":"Bi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-5979","authenticated-orcid":false,"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107637_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2024.107691","article-title":"Autophagy in myocardial ischemia and ischemia\/reperfusion","volume":"74","author":"Aljakna Khan","year":"2025","journal-title":"Cardiovasc. Pathol"},{"issue":"48","key":"10.1016\/j.ejps.2026.107637_bib0032","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1039\/C7TB01689A","article-title":"Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries","volume":"5","author":"Amani","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0035","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/s41598-019-42633-9","article-title":"Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling","volume":"9","author":"Amani","year":"2019","journal-title":"Sci. Rep"},{"issue":"3","key":"10.1016\/j.ejps.2026.107637_bib0039","article-title":"Myocardial infarction from a tissue engineering and regenerative medicine point of view: a comprehensive review on models and treatments","volume":"3","author":"Basara","year":"2022","journal-title":"Biophys. Rev. (Melville)"},{"key":"10.1016\/j.ejps.2026.107637_bib0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00002512-200118050-00007","article-title":"Indobufen: an updated review of its use in the management of atherothrombosis","volume":"18","author":"Bhana","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejps.2026.107637_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109824","article-title":"Fibroblast contributions to ischemic cardiac remodeling","volume":"77","author":"Burke","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.ejps.2026.107637_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2025.107465","article-title":"Indobufen versus aspirin in patients with indication for antiplatelet therapy: a systematic review and meta-analysis","volume":"158","author":"Cavalcante","year":"2025","journal-title":"Vascul. Pharmacol"},{"key":"10.1016\/j.ejps.2026.107637_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/245037","article-title":"Clinical use of aspirin in treatment and prevention of cardiovascular disease","volume":"2012","author":"Dai","year":"2012","journal-title":"Thrombosis"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12916-024-03374-3","article-title":"Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry","volume":"22","author":"Dai","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.ejps.2026.107637_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110714","article-title":"The role of PI3K\/AKT signaling pathway in myocardial ischemia-reperfusion injury","volume":"123","author":"Deng","year":"2023","journal-title":"Int. Immunopharmacol"},{"issue":"27","key":"10.1016\/j.ejps.2026.107637_bib0028","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J"},{"issue":"18","key":"10.1016\/j.ejps.2026.107637_bib0006","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jacc.2024.05.084","article-title":"Aspirin hypersensitivity in patients with atherosclerotic cardiovascular disease","volume":"84","author":"Galli","year":"2024","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.ejps.2026.107637_bib0005","article-title":"Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) collaborative group","volume":"12","year":"1988","journal-title":"J. Am. Coll. Cardiol"},{"issue":"10258","key":"10.1016\/j.ejps.2026.107637_bib0001","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"2019 diseases and injuries collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2026.107637_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106439","article-title":"Cardiac tissue engineering for myocardial infarction treatment","volume":"185","author":"Gil-Cabrerizo","year":"2023","journal-title":"Eur. J. Pharm. Sci"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10347","article-title":"Electrically conductive carbon-based (bio)-nanomaterials for cardiac tissue engineering","volume":"8","author":"Jalilinejad","year":"2022","journal-title":"Bioeng Transl. Med"},{"issue":"6","key":"10.1016\/j.ejps.2026.107637_bib0030","doi-asserted-by":"crossref","first-page":"H2261","DOI":"10.1152\/ajpheart.01056.2010","article-title":"Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion","volume":"300","author":"Kanamori","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"issue":"3","key":"10.1016\/j.ejps.2026.107637_bib0008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-022-01546-6","article-title":"Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury","volume":"71","author":"Khan","year":"2022","journal-title":"Inflamm. Res"},{"issue":"4","key":"10.1016\/j.ejps.2026.107637_bib0024","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4616","article-title":"Isolation and culture of primary fibroblasts from neonatal murine hearts to study cardiac fibrosis","volume":"13","author":"Kumar","year":"2023","journal-title":"Bio. Protoc"},{"issue":"4","key":"10.1016\/j.ejps.2026.107637_bib0022","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11481-020-09978-9","article-title":"Pretreatment of Indobufen and Aspirin and their combinations with clopidogrel or ticagrelor alleviates inflammasome mediated Pyroptosis Via inhibiting NF-\u03baB\/NLRP3 pathway in ischemic stroke","volume":"16","author":"Li","year":"2021","journal-title":"J. Neuroimmune Pharmacol"},{"issue":"4","key":"10.1016\/j.ejps.2026.107637_bib0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/aps.2016.143","article-title":"Aspirin alleviates cardiac fibrosis in mice by inhibiting autophagy","volume":"38","author":"Liu","year":"2017","journal-title":"Acta Pharmacol. Sin"},{"issue":"6","key":"10.1016\/j.ejps.2026.107637_bib0023","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/molecules23061452","article-title":"Anticoagulant activities of Indobufen, an antiplatelet drug","volume":"23","author":"Liu","year":"2018","journal-title":"Molecules"},{"issue":"25","key":"10.1016\/j.ejps.2026.107637_bib0027","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1161\/CIRCULATIONAHA.111.041814","article-title":"Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia\/reperfusion injury","volume":"125","author":"Ma","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejps.2026.107637_bib0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2017.03.001","article-title":"Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps","volume":"38","author":"Ma","year":"2017","journal-title":"Trends Pharmacol. Sci"},{"issue":"8","key":"10.1016\/j.ejps.2026.107637_bib0026","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tem.2015.05.010","article-title":"AMPK: energy sensor and survival mechanism in the ischemic heart","volume":"26","author":"Qi","year":"2015","journal-title":"Trends Endocrinol. Metab"},{"issue":"6","key":"10.1016\/j.ejps.2026.107637_bib0018","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41401-021-00763-9","article-title":"Asiatic acid alleviates ischemic myocardial injury in mice by modulating mitophagy- and glycophagy-based energy metabolism","volume":"43","author":"Qiu","year":"2022","journal-title":"Acta Pharmacol. Sin"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0041","first-page":"182","article-title":"Prevascularized micro-\/nano-sized spheroid\/bead aggregates for vascular tissue engineering","volume":"13","author":"Rahimnejad","year":"2021","journal-title":"Nanomicro Lett"},{"issue":"11","key":"10.1016\/j.ejps.2026.107637_bib0003","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/CIRCULATIONAHA.124.068739","article-title":"Excess mortality and loss of life expectancy after myocardial infarction: a registry-based matched cohort study","volume":"150","author":"Reitan","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejps.2026.107637_bib0009","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/ATVBAHA.123.320045","article-title":"Prostanoids in cardiac and vascular remodeling","volume":"44","author":"Ricciotti","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0014","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17512433.2025.2611291","article-title":"The efficacy and safety of indobufen versus aspirin in patients with acute myocardial infarction: a retrospective observational study","volume":"19","author":"Sasmita","year":"2026","journal-title":"Expert Rev. Clin. Pharmacol"},{"key":"10.1016\/j.ejps.2026.107637_bib0033","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.2147\/IJN.S467219","article-title":"Advanced nanomedicine approaches for myocardial infarction treatment","volume":"19","author":"Song","year":"2024","journal-title":"Int. J. Nanomed"},{"issue":"13","key":"10.1016\/j.ejps.2026.107637_bib0021","first-page":"7381","article-title":"Autophagy assuages myocardial infarction through Nrf2 signaling activation-mediated reactive oxygen species clear","volume":"24","author":"Sun","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"issue":"8","key":"10.1016\/j.ejps.2026.107637_bib0002","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ejps.2026.107637_bib0025","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/cells11091553","article-title":"Insight into the role of the PI3K\/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart","volume":"11","author":"Walkowski","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ejps.2026.107637_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008024","article-title":"Inflammation, autophagy, and apoptosis after myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J. Am. Heart Assoc"},{"issue":"3","key":"10.1016\/j.ejps.2026.107637_bib0013","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.122.062762","article-title":"Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation (OPTION): a randomized, open-label, end point-blinded, Noninferiority Trial","volume":"147","author":"Wu","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejps.2026.107637_bib0029","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s12015-025-10888-7","article-title":"Post-myocardial infarction cardiac remodeling: multidimensional mechanisms and clinical prospects of stem cell therapy","volume":"21","author":"Yong","year":"2025","journal-title":"Stem Cell Rev. Rep"},{"issue":"10","key":"10.1016\/j.ejps.2026.107637_bib0017","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/antiox14101263","article-title":"Roles of autophagy and oxidative stress in cardiovascular disease","volume":"14","author":"Yun","year":"2025","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0019","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target Ther"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0036","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target Ther"},{"issue":"1","key":"10.1016\/j.ejps.2026.107637_bib0007","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s41467-019-09492-4","article-title":"The cyclooxygenase-1\/mPGES-1\/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury","volume":"10","author":"Zhu","year":"2019","journal-title":"Nat. Commun"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:38:37Z","timestamp":1788993517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0928098726002113"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107637","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential myocardial responses to indobufen and aspirin across clinical and experimental models of myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107637"}}